Opportunity Information: Apply for W81XWH 13 OCRP TIA
Apply for W81XWH 13 OCRP TIA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Ovarian Cancer Teal Innovator Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Apr 27, 2013 and posted on Apr 27, 2013.
- Applicants must submit their applications by Aug 28, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $4,200,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Ovarian Cancer Teal Innovator Award (Funding Opportunity Number W81XWH-13-OCRP-TIA) is a Department of Defense Ovarian Cancer Research Program (OCRP) funding opportunity run through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It is designed to bring a single, exceptionally accomplished, highly visible scientific leader into ovarian cancer research, especially someone whose primary expertise comes from outside the ovarian cancer field (though ovarian cancer specialists are not excluded). The central idea is to intentionally recruit a "teal innovator" who can import fresh concepts, unconventional methods, and new technical capabilities into ovarian cancer research or patient care, with the expectation that this cross-pollination could produce a step-change rather than incremental progress.
The award emphasizes creativity, leadership, and bold thinking over safer, incremental projects. It explicitly supports novel, visionary, high-risk ideas that may be too early, too unconventional, or too disruptive for typical funding mechanisms, but that could have major downstream impact if successful. The program language makes clear that the Principal Investigator is meant to have unusual freedom to pursue their most innovative concepts, which signals that the funder is intentionally tolerating scientific risk in exchange for the possibility of outsized payoff for ovarian cancer patients.
A key eligibility and competitiveness requirement is the stature of the proposed Teal Innovator. Applicants are expected to be widely recognized leaders with strong evidence of national or international distinction. The announcement provides examples of qualifying recognition, such as holding an endowed chair, membership in the National Academy of Sciences or National Academy of Engineering, membership in the Institute of Medicine (now the National Academy of Medicine), chairing the American Association for Cancer Research, or comparable high-level recognition. In practice, this means the program is targeting established innovators with a track record of influential work, not early-career investigators, and not simply anyone with an interest in ovarian cancer.
From an administrative standpoint, the opportunity is categorized as discretionary funding and supports either a cooperative agreement or a grant as the funding instrument type. It falls under the Science and Technology and other Research and Development activity category, with CFDA number 12.420 (Military Medical Research and Development). Cost sharing or matching is not required. Eligibility is listed as unrestricted, meaning applications may come from any type of applicant entity unless additional restrictions are stated elsewhere in the full announcement.
In terms of scale and competitiveness, the opportunity anticipates making only one award, with an estimated total funding amount of $4,200,000. The posting date and creation date are April 27, 2013, with an original and current closing date of August 28, 2013, and an archive date of September 27, 2013. Because only one award was expected, the selection bar is inherently very high, and the program is essentially a flagship investment in one person and one transformative research vision rather than a broad portfolio of smaller projects.
For applicants or institutions needing help accessing the full announcement, the listed contact is the CDMRP Help Desk at 301-682-5507 or help@cdmrp.org.
FAQs: DoD Ovarian Cancer Teal Innovator Award (W81XWH-13-OCRP-TIA)
What is the DoD Ovarian Cancer Teal Innovator Award?
The Teal Innovator Award is a funding opportunity under the Department of Defense (DoD) Ovarian Cancer Research Program (OCRP), administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It is intended to recruit a single, exceptionally accomplished scientific leader to bring transformative ideas and capabilities into ovarian cancer research or patient care.
What is the main goal of this award?
The central goal is to intentionally bring in a highly visible "teal innovator" who can inject fresh concepts, unconventional methods, and new technical capabilities into ovarian cancer research or clinical impact, aiming for a step-change in progress rather than incremental advances.
Who is this award designed to support?
This award targets one exceptionally accomplished, widely recognized scientific leader. It especially encourages leaders whose primary expertise is outside the ovarian cancer field, although ovarian cancer specialists are not excluded.
Are ovarian cancer researchers excluded from applying?
No. While the program is particularly interested in recruiting innovators from outside the ovarian cancer field, it does not exclude ovarian cancer specialists.
What kind of research approach does the award emphasize?
The award emphasizes creativity, leadership, and bold thinking. It explicitly supports novel, visionary, high-risk ideas that may be too early, too unconventional, or too disruptive for typical funding mechanisms, but that could have major downstream impact if successful.
Does the funder expect high-risk projects?
Yes. The program language signals a deliberate tolerance for scientific risk in exchange for the possibility of outsized payoff for ovarian cancer patients.
What does it mean to be a "Teal Innovator" in this context?
In this program, a Teal Innovator is an exceptionally accomplished, highly visible scientific leader expected to import new ideas and capabilities into ovarian cancer research or patient care. The concept is based on cross-pollination: bringing approaches from other fields to create potentially transformative impact.
How important is the Principal Investigator's stature for eligibility and competitiveness?
The stature of the proposed Teal Innovator is a key requirement and a major competitiveness factor. Applicants are expected to be widely recognized leaders with strong evidence of national or international distinction.
What are examples of the kinds of recognition that demonstrate the required stature?
The announcement provides examples such as holding an endowed chair, membership in the National Academy of Sciences (NAS) or National Academy of Engineering (NAE), membership in the Institute of Medicine (now the National Academy of Medicine), chairing the American Association for Cancer Research (AACR), or comparable high-level recognition.
Is this award aimed at early-career investigators?
No. The program is targeting established innovators with influential track records and high visibility, not early-career investigators.
How many awards were anticipated under this opportunity?
Only one award was anticipated, making this a flagship investment in one person and one transformative research vision.
What is the estimated total funding amount?
The estimated total funding amount is $4,200,000.
What is the Funding Opportunity Number for this program?
The Funding Opportunity Number is W81XWH-13-OCRP-TIA.
Which program and agencies run this opportunity?
This opportunity is part of the DoD Ovarian Cancer Research Program (OCRP) and is run through the U.S. Army Medical Research Acquisition Activity (USAMRAA).
What type of funding instrument is used?
The opportunity supports either a cooperative agreement or a grant as the funding instrument type.
How is this opportunity categorized (activity area/type)?
It falls under the Science and Technology and other Research and Development activity category and is categorized as discretionary funding.
What is the CFDA number associated with this opportunity?
The CFDA number is 12.420 (Military Medical Research and Development).
Is cost sharing or matching required?
No. Cost sharing or matching is not required.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning applications may come from any type of applicant entity unless additional restrictions are stated elsewhere in the full announcement.
When was this opportunity posted?
The posting date (and creation date) is April 27, 2013.
What were the closing dates for submitting applications?
The original and current closing date listed is August 28, 2013.
When was the opportunity archived?
The archive date is September 27, 2013.
Why is this opportunity considered highly competitive?
Because only one award was expected, the selection bar is inherently very high. The program is structured as a single, major investment rather than a broad portfolio of multiple smaller awards.
What should applicants do if they need help accessing the full announcement?
For assistance, applicants or institutions can contact the CDMRP Help Desk at 301-682-5507 or help@cdmrp.org.
What is the expected impact if a project is successful?
The program is designed to enable ideas that could produce major downstream impact for ovarian cancer patients, with the expectation of potentially transformative progress rather than incremental improvements.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DoD Ovarian Cancer Academy Award Early Career Investigator
Previous opportunity: DoD Ovarian Cancer Pilot Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 13 OCRP TIA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 13 OCRP TIA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Ovarian Cancer Academy Award Early Career Investigator Apply for W81XWH 13 OCRP OCA Funding Number: W81XWH 13 OCRP OCA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Gas Turbine Upgrades for Reduced Total Ownership Cost (TOC) and Improved Ship Impact Apply for ONRBAA13 013 Funding Number: ONRBAA13 013 Agency: Office of Naval Research Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Great Lakes Northern Forests CESU Apply for G13AS00040 Funding Number: G13AS00040 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2013 Heliophysics Supporting Research Apply for NNH13ZDA001N HSR Funding Number: NNH13ZDA001N HSR Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2013 Astrophysics Theory Program Apply for NNH13ZDA001N ATP Funding Number: NNH13ZDA001N ATP Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2013 Heliophysics Infrastructure and Data Environment Enhancements Apply for NNH13ZDA001N HIDEE Funding Number: NNH13ZDA001N HIDEE Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2013 The GLOBE Implementation Office Apply for NNH13ZDA001N GLOBE Funding Number: NNH13ZDA001N GLOBE Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Ecosystem Studies Unit, Colorado Plateau CESU Apply for G13AS00042 Funding Number: G13AS00042 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Physics Frontiers Centers Apply for 13 559 Funding Number: 13 559 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
| Arrays at Commercial Timescales (ACT) Apply for DARPA BAA 13 26 Funding Number: DARPA BAA 13 26 Agency: DARPA Microsystems Technology Office Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2013 Carbon Monitoring System Continuing Prototype Product Development, Research, and Scoping Apply for NNH13ZDA001N CMS Funding Number: NNH13ZDA001N CMS Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2013 Ocean Salinity Science Team Apply for NNH13ZDA001N OSST Funding Number: NNH13ZDA001N OSST Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Defense Sciences Research and Technology Apply for DARPA BAA 13 20 Funding Number: DARPA BAA 13 20 Agency: DARPA Defense Sciences Office Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Instrument Development for Biological Research Apply for 13 561 Funding Number: 13 561 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2013 Instrument Concepts for Europa Exploration Apply for NNH13ZDA001N ICEE Funding Number: NNH13ZDA001N ICEE Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Multiple Sclerosis Idea Development Award Apply for W81XWH 13 MSRP IDA Funding Number: W81XWH 13 MSRP IDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Amyotrophic Lateral Sclerosis Therapeutic Idea Award Apply for W81XWH 13 ALSRP TIA Funding Number: W81XWH 13 ALSRP TIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Amyotrophic Lateral Sclerosis Therapeutic Development Award Apply for W81XWH 13 ALSRP TDA Funding Number: W81XWH 13 ALSRP TDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Neurofibromatosis Exploration Hypothesis Development Award Apply for W81XWH 13 NFRP EHDA Funding Number: W81XWH 13 NFRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Neurofibromatosis New Investigator Award Apply for W81XWH 13 NFRP NIA Funding Number: W81XWH 13 NFRP NIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 13 OCRP TIA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.